Inflammatix
Inflammatix develops novel molecular diagnostics for acute infections and sepsis that work by 'reading' the immune system. It is a molecular diagnostics company developing rapid tests that read the immune system to resolve major clinical and public health challenges. They are initially focused on developing tests for acute bacterial and viral infections, and sepsis based on patent-pending biomarkers exclusively licensed from Stanford University.
Domain
inflammatix.com
Country
United StatesIndustry
BioinformaticsEmployees
51-100
Last Funding
$57.0M
Founded
2015
Tech Stack (20 technologies)
Frequently Asked Questions
What technologies does Inflammatix use?+
Inflammatix uses 20 technologies including Google Analytics, Google Tag Manager, WordPress.
What industry is Inflammatix in?+
Inflammatix operates in the Bioinformatics industry.
Where is Inflammatix based?+
Inflammatix is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026